Dogwood Therapeutics Inc Share Price

NASDAQ: DWTX

Small Cap

$4.95

+0.08

(+1.63%)

Live

as on September 16, 2025 at 7:26 pm IST

$₹

Dogwood Therapeutics Inc Stock Performance

as on September 16, 2025 at 7:26 pm IST

Day's Low
$4.88
Day's Price Range
$4.95
$4.95
1.41%
Downside
52 Week's Low
52 Week's High
$1.62
52-Week Price Range
$29.28
$4.95
67.27%
Downside
491.52%
Upside

Dogwood Therapeutics Inc share price movements today

Previous Close: $4.87
Open: $4.88
Volume: 8.0K
Day's Low - High: $4.88 - $4.95
52 Week Low - High: $1.62 - $29.28

Dogwood Therapeutics Inc Historical Returns

1 Month Return: -0.81 %
3 Month Return: + 2.09 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Dogwood Therapeutics Inc Stock Fundamentals & Key Indicators

Check Dogwood Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$9.3M

EPS (TTM)

-8.9967

Dividend Yield

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

Return On Equity TTM

14060100.00%

Dogwood Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Dogwood Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Dogwood Therapeutics Inc	NA	$9.3M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$61.1B	251.26%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$101.2B	47.46%	28.09	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.6B	0.6%	14.1	31.37%

Dogwood Therapeutics Inc Stock's Interest Amongst Investors

Search interest for Dogwood Therapeutics Inc Stock has increased by 50% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 17, 2025 to September 16, 2025

Change:50% versus previous 30 day period

Dogwood Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	0	0	0
Operating Income	-1	-1	-1	-1	-1	-2	-7	-4	-3
EBITDA	-1	-1	-1	-1	-1	-2	-7	-10	-3
Interest Expense	-	-	-	-	-	-	0	0	-
Depreciation	-	-	-	-	-	-	-	0	0
Income Before Tax	-1	-1	-1	-1	-1	-2	-7	-10	-3
Income Tax Expense	-	-	-	-	-	-	0	0	0
Net Income	-1	-1	-1	-1	-1	-2	-7	-10	-3
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Dogwood Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	0
Operating Income	-10	-15	-12	-5	-12
EBITDA	-10	-15	-12	-5	-12
Interest Expense	0	-	-	-	0
Depreciation	-	-	-	-	0
Income Before Tax	-10	-15	-12	-5	-12
Income Tax Expense	-	-	-	-	0
Net Income	-10	-15	-12	-5	-12
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%

Dogwood Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-1	-1	-1	-1	-1	-2	-7	-10	-3
Operating Cash Flow	0	0	-1	0	0	0	-6	-4	-4
Investing Cash Flow	-	-	-	-	-	-	3	-	-
Financing Cash Flow	-	1	-	-	1	0	15	7	0
Change in Cash	0	0	-1	0	0	0	12	2	-4

Dogwood Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-2	-10	-15	-12	-5	-12
Operating Cash Flow	-2	-3	-15	-11	-4	-8
Investing Cash Flow	-	-	-	-	-	3
Financing Cash Flow	2	33	0	4	1	16
Change in Cash	0	29	-15	-6	-3	11

Insights on Dogwood Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 70.6% return, outperforming this stock by 71.0%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 214.3%
NEGATIVE IMPACT
Price Dip
In the last 3 years, DWTX stock has moved down by -97.8%

About Dogwood Therapeutics Inc

Dogwood Therapeutics, Inc. is a development-stage biopharmaceutical company focused on developing new medicines to treat pain and fatigue-related disorders. The Company’s research pipeline includes two separate mechanistic platforms with a non-opioid analgesic program and an antiviral program. The proprietary, non-opioid, Nav 1.7 analgesic program is centered on its lead development candidate, Halneuron, which is a specific voltage-gated sodium channel modulator, a mechanism known to be effective for reducing pain transmission. In clinical studies, Halneuron treatment has demonstrated pain reduction in pain related to general cancer and in pain related to chronic chemotherapy-induced neuropathic pain (CINP). The Company’s antiviral program includes IMC-1 and IMC-2, which are fixed-dose combinations of nucleoside analog, anti-herpes antivirals and the anti-inflammatory agent celecoxib for the treatment of fibromyalgia (FM) and Long-COVID (LC).

Organisation	Dogwood Therapeutics Inc
Headquarters	44 Milton Avenue, Alpharetta, GA, United States, 30009
CEO	Mr. Gregory Duncan
E-voting on shares	Click here to vote

Key Management of Dogwood Therapeutics Inc

Name	Title
Ms. Carol Duffy Ph.D.	Chief Scientific Advisor
Mr. Gregory Duncan	Chairman & CEO
Dr. William L. Pridgen M.D.	Founder & Member of Scientific Advisory Board
Ms. Angela Walsh	Chief Financial Officer, Secretary & Treasurer
Dr. R. Michael Gendreau M.D., Ph.D.	Chief Medical Officer
Mr. Ralph D. Grosswald M.P.H.	Senior Vice President of Operations

FAQs

What is Dogwood Therapeutics Inc share price today?

Dogwood Therapeutics Inc share price today is $4.95 as on September 16, 2025 at 7:26 pm IST. Dogwood Therapeutics Inc share today touched a day high of $4.95 and a low of $4.88.

What is the 52 week high and 52 week low for Dogwood Therapeutics Inc share?

Dogwood Therapeutics Inc share touched a 52 week high of $29.28 on January 23, 2025 and a 52 week low of $1.62 on November 18, 2024. Dogwood Therapeutics Inc stock price today i.e. September 16, 2025 at 7:26 pm IST is trending at $4.95,which is 83.09% down from its 52 week high and 205.56% up from its 52 week low.

What is Dogwood Therapeutics Inc's market capitalisation today?

Dogwood Therapeutics Inc market capitalisation is $0.00T as on September 16, 2025 at 7:26 pm IST.

How to invest in Dogwood Therapeutics Inc Stock (DWTX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Dogwood Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Dogwood Therapeutics Inc Shares that will get you 0.3030 shares as per Dogwood Therapeutics Inc share price of $4.95 per share as on September 16, 2025 at 7:26 pm IST.

What is the minimum amount required to buy Dogwood Therapeutics Inc Stock (DWTX) from India?

Indian investors can start investing in Dogwood Therapeutics Inc (DWTX) shares with as little as ₹88.042 or $1 (as of September 16, 2025 at 7:41 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹880.42 in Dogwood Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on September 16, 2025 at 7:41 pm IST). Based on Dogwood Therapeutics Inc share’s latest price of $4.95 as on September 16, 2025 at 7:26 pm IST, you will get 2.0202 shares of Dogwood Therapeutics Inc. Learn more about fractional shares .